Editorial comment on: cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones.
Poulakis
Vassilis
V
D000317:Adrenergic alpha-Antagonists / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D008297:Male; D019370:Observation; D013449:Sulfonamides / Q000191:economics* / Q000627:therapeutic use*; D000077409:Tamsulosin; D014421:Turkey / Q000453:epidemiology; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D014514:Ureteral Calculi / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology
D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin